Click-bait headline. It doesn't say Medicare has decided to cover it yet, it's under review. And only some privately administered Medicare plans have decided

Click-bait headline. It doesn't say Medicare has decided to cover it yet, it's under review. And only some privately administered Medicare plans have decided to cover it. Some hospital systems are doubting the efficacy and refuse to administer it. No doubt, it's a huge market. But the fact that it's a monthly infusion makes it a tough proposition. Sovaldi was a miracle drug, priced like a Bentley. This drug is no miracle drug, but they priced it like one.